Bath & Body Works, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q4 2009 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Bath & Body Works, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2009 to Q3 2024.
  • Bath & Body Works, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending November 2, 2024 was -$1.75B, a 17.7% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$1.75B +$376M +17.7% Nov 2, 2024 10-Q 2024-11-26
Q2 2024 -$1.72B +$436M +20.2% Aug 3, 2024 10-Q 2024-11-26
Q1 2024 -$1.68B +$494M +22.8% May 4, 2024 10-Q 2024-08-28
Q4 2023 -$1.63B +$579M +26.3% Feb 3, 2024 10-Q 2024-11-26
Q3 2023 -$2.12B +$484M +18.6% Oct 28, 2023 10-Q 2024-11-26
Q2 2023 -$2.15B +$508M +19.1% Jul 29, 2023 10-Q 2024-11-26
Q1 2023 -$2.17B +$488M +18.4% Apr 29, 2023 10-Q 2024-08-28
Q4 2022 -$2.21B -$688M -45.4% Jan 28, 2023 10-Q 2024-11-26
Q3 2022 -$2.61B -$933M -55.7% Oct 29, 2022 10-Q 2023-12-01
Q2 2022 -$2.66B -$1.47B -124% Jul 30, 2022 10-Q 2023-12-01
Q1 2022 -$2.66B -$2.13B -399% Apr 30, 2022 10-Q 2023-09-01
Q4 2021 -$1.52B -$856M -130% Jan 29, 2022 10-K 2024-03-22
Q3 2021 -$1.68B -$111M -7.1% Oct 30, 2021 10-Q 2022-11-30
Q2 2021 -$1.19B +$716M +37.6% Jul 31, 2021 10-Q 2022-11-30
Q1 2021 -$533M +$1.33B +71.3% May 1, 2021 10-Q 2022-09-02
Q4 2020 -$661M +$834M +55.8% Jan 30, 2021 10-K 2024-03-22
Q3 2020 -$1.56B -$326M -26.3% Oct 31, 2020 10-Q 2021-12-03
Q2 2020 -$1.9B -$975M -105% Aug 1, 2020 10-Q 2021-12-03
Q1 2020 -$1.86B -$960M -107% May 2, 2020 10-Q 2021-09-02
Q4 2019 -$1.5B -$630M -72.8% Feb 1, 2020 10-K 2023-03-17
Q3 2019 -$1.24B +$74M +5.64% Nov 2, 2019 10-Q 2020-12-04
Q2 2019 -$929M +$193M +17.2% Aug 3, 2019 10-Q 2020-12-04
Q1 2019 -$898M +$71M +7.33% May 4, 2019 10-Q 2020-09-03
Q4 2018 -$865M -$114M -15.2% Feb 2, 2019 10-K 2022-03-18
Q3 2018 -$1.31B -$193M -17.2% Nov 3, 2018 10-Q 2019-12-06
Q2 2018 -$1.12B -$210M -23% Aug 4, 2018 10-Q 2019-12-06
Q1 2018 -$969M -$134M -16% May 5, 2018 10-Q 2019-09-06
Q4 2017 -$751M -$24M -3.3% Feb 3, 2018 10-K 2021-03-19
Q3 2017 -$1.12B +$69M +5.81% Oct 28, 2017 10-Q 2018-12-04
Q2 2017 -$912M +$217M +19.2% Jul 29, 2017 10-Q 2018-09-07
Q1 2017 -$835M +$251M +23.1% Apr 29, 2017 10-Q 2018-06-07
Q4 2016 -$727M -$469M -182% Jan 28, 2017 10-K 2020-03-30
Q3 2016 -$1.19B -$531M -80.8% Oct 29, 2016 10-Q 2017-12-01
Q2 2016 -$1.13B -$482M -74.5% Jul 30, 2016 10-Q 2017-09-01
Q1 2016 -$1.09B -$480M -79.2% Apr 30, 2016 10-Q 2017-06-02
Q4 2015 -$258M -$277M -1458% Jan 30, 2016 10-K 2019-03-22
Q3 2015 -$657M -$224M -51.7% Oct 31, 2015 10-Q 2016-12-02
Q2 2015 -$647M -$144M -28.6% Aug 1, 2015 10-Q 2016-09-02
Q1 2015 -$606M +$3M +0.49% May 2, 2015 10-Q 2016-06-03
Q4 2014 $19M +$388M Jan 31, 2015 10-K 2018-03-23
Q3 2014 -$433M +$387M +47.2% Nov 1, 2014 10-Q 2015-12-04
Q2 2014 -$503M +$358M +41.6% Aug 2, 2014 10-Q 2015-09-04
Q1 2014 -$609M +$385M +38.7% May 3, 2014 10-Q 2015-06-05
Q4 2013 -$369M +$645M +63.6% Feb 1, 2014 10-K 2017-03-17
Q3 2013 -$820M -$305M -59.2% Nov 2, 2013 10-Q 2014-12-05
Q2 2013 -$861M -$616M -251% Aug 3, 2013 10-Q 2014-09-05
Q1 2013 -$994M -$863M -659% May 4, 2013 10-Q 2014-06-06
Q4 2012 -$1.01B -$1.15B -835% Feb 2, 2013 10-K 2016-03-18
Q3 2012 -$515M -$1.04B -199% Oct 27, 2012 10-Q 2013-12-06
Q2 2012 -$245M -$870M -139% Jul 28, 2012 10-Q 2013-09-06
Q1 2012 -$131M -$1.26B -112% Apr 28, 2012 10-Q 2013-06-07
Q4 2011 $138M -$1.34B -90.7% Jan 28, 2012 10-K 2015-03-20
Q3 2011 $521M -$1.52B -74.5% Oct 29, 2011 10-Q 2012-11-30
Q2 2011 $625M -$1.45B -69.9% Jul 30, 2011 10-Q 2012-08-31
Q1 2011 $1.13B -$850M -43% Apr 30, 2011 10-Q 2012-06-01
Q4 2010 $1.48B -$707M -32.4% Jan 29, 2011 10-K 2014-03-21
Q3 2010 $2.04B Oct 30, 2010 10-Q 2011-12-02
Q2 2010 $2.07B Jul 31, 2010 10-Q 2011-08-31
Q1 2010 $1.98B May 1, 2010 10-Q 2011-06-03
Q4 2009 $2.18B Jan 30, 2010 10-K 2013-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.